Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, has launched new embolic coils platform to treat brain aneurysms.
The new coils are supported by an enhanced detachment system, which is designed to improve microcatheter stability and provide an optimized detachment zone.
Codman Neuro worldwide president Laxmin Laxminarain said: "Coupled with a new, softer delivery system, our coil platform is designed to improve how aneurysms are treated, and is an example of the continued commitment of Codman Neuro to innovation in neurovascular care."
Used during a minimally invasive endovascular procedure, the family of framing, filling and finishing coils have been designed to help doctors individualize intervention based on the unique anatomy of the aneurysm.
The company is offering different coil shapes for each step of the procedure, including Micrusframe coils for framing, Galaxy G3 coils for filling and Deltaxsft coils for finishing.
Micrusframe, Deltafill, Deltasft and Galaxy G3 microcoil delivery systems are developed for endovascular embolization of intracranial aneurysms and other neurovascular abnormalities, including arteriovenous malformations and arteriovenous fistulae.
They are also intended for arterial and venous embolizations in the peripheral vasculature.
The coils feature Deltawind technology, which was designed with multiple natural micro-deflection points. The technology will enable the coils to easily change direction, allowing the coils to seek and fill open spaces and be uniformly distributed to facilitate increased packing density.